Capha Pharmaceuticals Inc. filed its Annual on Apr 29, 2022 for the period ending Dec 31, 2021. In this report its auditor, Dyke & Howard - D & H Group LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.